Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4434_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Foreword
- •Foreword
- •Preface
- •Acknowledgment
- •Contents
- •About the Editors
- •1.1 Introduction
- •1.6 Dissection Procedure
- •1.6.2 Dissection Guide
- •1.9 Conclusion
- •References
- •2.1 Introduction
- •1.5.3 Sentinel Lymph Node Biopsy
- •2.3.1 Oral Cavity Surgery
- •2.3.2 Pharyngeal Surgery
- •2.3.3 Transoral Robotic Surgery (TORS)
- •2.4 Laryngeal Surgery
- •2.6 Salivary Gland Surgery
- •2.7 Thyroid Gland Surgery
- •2.8 Neck Dissection
- •2.9.1 Paediatric Surgery
- •2.10 Anatomical Versus Surgical Landmarks
- •2.13 Conclusion
- •References
- •3.1 Introduction
- •3.6.1 Pharynx
- •3.6.2 Nasopharyngeal Surgery
- •3.6.6 Temporal Bone Surgery
- •3.7 Conclusion
- •References
- •4.2.1 Perineural Tumour Spread
- •4.2.2 Carotid Artery Involvement
- •4.3.1 Oral Cavity
- •4.3.2 Nasopharynx
- •4.3.3 Oropharynx
- •4.3.4 Hypopharynx
- •4.3.5 Larynx
- •4.4.1 Oral Cavity Squamous Cell Carcinoma
- •4.4.2 Oropharyngeal Squamous Cell Carcinoma
- •4.4.3 Nasopharyngeal Squamous Cell Carcinoma
- •4.4.4 Non-HPV Oropharyngeal Squamous Cell Carcinoma
- •4.4.5 Unknown Primary Tumours
- •4.5 Lymph Nodes
- •4.5.1 Introduction
- •4.5.2.1 Clustering
- •4.5.2.2 Morphology
- •4.5.2.3 Inhomogeneity
- •4.5.2.4 Size
- •4.5.2.5 Lymphatic Drainage
- •4.6 Advanced Imaging
- •4.6.1 Elastography
- •4.6.2 DWI-MRI
- •4.7.1 Introduction
- •4.11 Cross-Sectional Imaging
- •References
- •5: Approach Towards Oral Cavity Cancers
- •5.1 Introduction
- •5.3 Diagnostic Evaluation
- •5.8.2.1 Access-Incision Planning
- •5.8.3 Surgical Techniques
- •5.8.3.1 Anaesthesia Considerations
- •5.8.4.1 Peroral Wide Local Excision
- •5.8.5.1 Access Osteotomy Through Mandibulotomy
- •5.8.5.2 Surgical Steps
- •5.8.5.3 Pull-Through Approach
- •5.8.5.4 Oral Component
- •5.8.5.5 Neck Component
- •5.8.6.1 Peroral Wide Local Excision
- •5.8.6.2.1 Surgical Steps
- •5.8.11 Hard Palate (T1–T2 Lesion)
- •5.8.11.1 Upper Alveolectomy
- •References
- •6.1 Benign Oropharyngeal Tumours
- •6.1.1 Lingual Thyroid
- •6.1.2 Epidemiology
- •6.1.3 Clinical Presentation
- •6.1.4 Histology
- •6.1.5 Imaging
- •6.1.6 Blood Investigation
- •6.1.7 Treatment
- •6.1.8 Surgical Treatment
- •6.1.9 Non-surgical Treatment
- •6.2 Pleomorphic Adenoma
- •6.2.1 Diagnosis
- •6.4.8 Early Stage
- •6.4.9 Advanced Stage
- •6.4.10 Non-surgical Treatment
- •6.4.11 Case Illustration 1
- •6.4.12 Case Illustration 2
- •6.5 Benign Hypopharyngeal Tumours
- •6.5.1 Fibrolipoma
- •6.2.3 Treatment
- •6.2.4 Case Illustration 1
- •6.3 Papilloma
- •6.3.1 Epidemiology
- •6.3.2 Clinical Presentation
- •6.3.3 Histology
- •6.3.4 Treatment
- •6.4.1 Risk Factors
- •6.4.2 Clinical Presentation
- •6.4.3 Diagnosis
- •6.4.4 Histology
- •6.4.5 Imaging
- •6.4.6 Staging
- •6.4.7 Treatment
- •6.6.1 Epidemiology
- •6.6.2 Risk Factor
- •6.6.3 Clinical Presentation
- •6.6.4 Diagnosis
- •6.6.5 Blood Investigations
- •6.6.6 Imaging
- •6.6.8 Histology
- •6.6.9 Staging
- •6.6.9.1 Primary Tumour (T)
- •6.6.9.2 Regional Lymph Node (N)
- •6.6.9.3 Distant Metastasis (M)
- •6.6.9.4 Stage Groups
- •6.6.10 Treatment
- •6.6.10.1 Surgical
- •References
- •7.1 Introduction
- •7.2 Salvage Neck Dissection
- •7.3.2.1 Procedure
- •7.3.2.2 Advantages
- •7.3.2.3 Disadvantages
- •7.3.3.1 Procedure
- •7.3.3.2 Advantages
- •7.3.3.3 Disadvantages
- •7.4.1 Procedure
- •7.4.2 Advantages
- •7.4.3 Disadvantages
- •7.5.1 Procedure
- •7.5.2 Advantages
- •7.5.3 Disadvantages
- •7.6 Subtemporal-Preauricular Infratemporal Fossa Approach
- •7.6.1 Procedure
- •7.6.2 Advantages
- •7.6.3 Disadvantages
- •7.7 Facial Translocation
- •7.7.1 Procedure
- •7.7.2 Advantages
- •7.7.3 Disadvantages
- •7.8 Endoscopic Endonasal Transpterygoid Nasopharyngectomy (EETN)
- •7.8.1 Patient Selection
- •7.8.2 Surgical Technique
- •7.8.2.1 Nasoseptal Flap
- •7.8.2.2 Sinonasal Corridor
- •7.8.2.3 Posterior Septectomy
- •7.8.2.4 Inferior Sphenoidectomy
- •7.8.2.5 Transpterygoid Dissection
- •7.8.2.6 Tumour Extirpation
- •7.10 Miscellaneous
- •7.11 Conclusion
- •References
- •8.1 Introduction
- •8.6 Parotid Gland Surgery
- •8.6.1 Benign Parotid Tumour Surgery
- •8.6.2 Malignant Parotid Tumour Surgery
- •8.7.1.2 Skin Incision
- •8.7.1.4 Greater Auricular Nerve Preservation
- •8.7.1.8 Facial Nerve Branch Preservation
- •8.7.1.10 Homeostasis Control
- •8.7.1.12 Post-operative Follow-Up
- •8.7.2.1 Case Illustration 1
- •8.8 Complications Post Parotidectomy
- •8.9.2 Post-operative Assessment
- •8.12 Conclusion
- •References
- •9.1 Introduction
- •9.2.1 Recurrent Laryngeal Nerve
- •9.2.3 Berry’s Ligament
- •9.2.4 Parathyroid Gland Anatomy
- •9.2.5 Inferior Thyroid Artery
- •9.2.6 Zuckerkandl Tubercle
- •9.5 Retrosternal Thyroid Tumour
- •9.7 Intraoperative Neural Monitoring
- •9.9 Thyroid Lobectomy
- •9.9.1 Case Illustration 1: Completion Hemithyroidectomy
- •9.10 Conclusion
- •References
- •10.1 Introduction
- •10.2 Surgical Anatomy
- •10.3 Indications
- •10.4.1 Patient Preparation
- •10.4.2 Informed Consent
- •10.4.3 Preoperative Planning/Evaluation
- •10.4.4.1 Antibiotic
- •10.4.4.2 Systemic Corticosteroid
- •10.4.4.3 Topical Decongestants
- •10.4.4.4 Adrenaline
- •10.4.5 Anaesthesia
- •10.4.7 Image-Guided System (IGS)
- •10.5 Operative Techniques
- •10.5.1 Endoscopic Sinus Surgery
- •10.5.1.1 Uncinectomy
- •10.5.1.2 Middle Meatal Antrostomy (MMA)
- •10.5.1.3 Ethmoidal Bullectomy
- •10.5.1.4 Posterior Ethmoidectomy
- •10.5.1.5 Sphenoidotomy
- •10.5.1.6 Frontal Sinusotomy
- •10.6 Intraoperative Complication
- •10.6.1 Intranasal Complications
- •10.6.1.2 Arterial Injury
- •10.6.1.2.1 Sphenopalatine Artery
- •10.6.1.2.2 Anterior Ethmoidal Artery (AEA)
- •10.6.1.2.3 Posterior Ethmoidal Artery (PEA)
- •10.6.1.2.4 Internal Carotid Artery (ICA)
- •Call for Help
- •Interventional Radiologist/Endovascular
- •10.6.2 Intraorbital Complications
- •10.6.2.2 Orbital Emphysema (Grade I)
- •10.6.2.3 Intraorbital Haematoma (Grade I)
- •10.6.2.5 Extraocular Muscle Injury (Grade III)
- •10.6.2.6 Optic Nerve Injury (Grade III)
- •10.6.3 Intracranial Complications
- •10.6.3.1 CSF Leak
- •10.6.4 Post-operative Complication
- •10.6.4.1 Epistaxis
- •10.6.4.2 Nasal Synechia
- •10.6.4.3 Other Complications
- •References
- •11.1 Introduction
- •11.2 Anatomical Landmarks
- •11.3 Background
- •11.4 Patient’s Preparation
- •11.5 Equipment
- •11.6 Positioning
- •11.7 Preoperative Evaluation
- •11.8 Infrastructure Maxillectomy
- •11.9 Subtotal Maxillectomy
- •11.10 Total Maxillectomy
- •11.12 Transoral-Transnasal Endoscopic Maxillectomy
- •11.13 Endoscopic-Assisted Transfacial Maxillectomy
- •11.14 Conclusion
- •References
- •12.1 Introduction
- •12.3 Laryngeal Diseases
- •12.4 Supraglottic Carcinoma
- •12.5 Glottic Carcinoma
- •12.6 Subglottic Carcinoma
- •12.8 Surgical Treatment
- •12.9.1 Skin Incision
- •12.9.5 Larynx Skeletonization
- •12.10 Open Partial Horizontal Laryngectomy (OPHL)
- •12.10.1.1 Surgical Technique
- •12.10.2.1 Surgical Technique
- •12.10.3.1 Surgical Technique
- •12.11 Total Laryngectomy
- •12.11.1 Surgical Technique
- •12.12 Future Challenges
- •12.13 Conclusion
- •References
- •13.1 Introduction
- •13.5 Central Compartment Neck Dissection
- •13.6 Selective Neck Dissection
- •13.7.1 Selective Neck Dissection
- •13.7.2 Case Illustration 1
- •13.7.3 Case Illustration 2
- •13.7.4 Case Illustration 3
- •13.9 Radical Neck Dissection
- •13.11 Prognosis
- •13.12 Conclusion
- •References
- •14.1 Introduction
- •14.3 Endoscopic Assisted Surgical Access
- •14.3.1 Endoscopic Thyroidectomy
- •14.7 Clavicle Osteotomy
- •14.7.1 Case Illustration
- •14.7.1.1 Case 1
- •14.8 Base-of-Neck Tumour
- •14.11 Conclusion
- •References
- •15.1 Introduction
- •15.2 Orbital Exenteration
- •15.2.1 Surgical Steps
- •15.2.1.1 Lid-Sparing Exenteration
- •15.2.1.2 Total Exenteration
- •15.2.2 Case Illustrations
- •15.2.3 Complications
- •15.4 Conclusion
- •References
- •16.1 Introduction
- •16.2.1 Benign Pathology
- •16.4 Vestibular Disorders
- •16.4.1 Ménière’s Disease
- •16.4.2 Superior Semicircular Canal Dehiscence
- •16.5.3 Temporal Bone Paraganglioma
- •16.6 Malignant Neoplasms
- •16.7.1 Diagnostic Audiology
- •16.7.2 Vestibular Tests
- •16.7.3 Imaging
- •16.8.2 Postauricular Incision
- •16.8.3 Transmeatal Incisions
- •16.8.4 Endaural Incisions
- •16.9 Anterior Atticotomy
- •16.10 Transmastoid Approaches
- •16.10.3 Posterior Tympanotomy
- •16.11 Endolymphatic Sac Decompression
- •16.12 Subtotal Petrosectomy
- •16.13 Translabyrinthine Approaches
- •16.14 Transcochlear Approach
- •16.16 Middle Cranial Fossa
- •16.19 Endoscopic Ear Surgery
- •16.19.1 Protympanum
- •16.19.2 Epitympanum
- •16.19.3 Retrotympanum
- •16.19.4 Hypotympanum
- •16.21 Conclusion
- •References
- •17.1 Introduction
- •17.2.1 Vascular Lesions
- •17.2.2 Infantile Haemangioma
- •17.2.2.1 Introduction
- •17.2.2.2 Epidemiology
- •17.2.2.3 Pathogenesis
- •17.2.2.4 Phases
- •17.2.2.4.1 Proliferative Phase
- •17.2.2.4.2 Involution Phase
- •17.2.2.5 Diagnosis
- •17.2.2.6 Treatment
- •17.2.2.7 Medical Therapy
- •17.2.2.8 Laser Therapy
- •17.2.2.9 Surgical Therapy
- •17.2.3 Dermoid Cyst
- •17.2.3.1 Introduction
- •17.2.3.3 Clinical Presentation
- •17.2.3.4 Imaging
- •17.2.3.5 Treatment
- •17.2.3.5.1 Surgery
- •17.3 Thyroglossal Duct Cyst
- •17.3.1 Introduction
- •17.3.2 Embryology
- •17.3.3 Clinical Presentation
- •17.3.4 Diagnosis
- •17.3.4.1 Blood Investigation
- •17.3.4.3 Histology
- •17.3.4.4 Imaging
- •17.3.5 Treatment
- •17.3.5.1 Surgery
- •17.3.5.2 Sclerotherapy
- •17.4 Rhabdomyosarcoma
- •17.4.1 Introduction
- •17.4.3 General Characteristics
- •17.4.4 Histology
- •17.4.5 Diagnosis
- •17.4.5.1 Biopsy
- •17.4.6 Staging
- •17.4.7 Treatment
- •17.4.7.1 Chemotherapy
- •17.4.7.2 Radiation Therapy
- •17.4.7.3 Surgical Therapy
- •17.4.8 Prognosis
- •17.4.9 Recurrence
- •17.5.1 Introduction
- •17.5.2 Epidemiology
- •17.5.3 Aetiology
- •17.5.4 Pathogenesis
- •17.5.5 Presentation
- •17.5.6 Diagnosis
- •17.5.7 Imaging
- •17.5.8 Histology
- •17.5.9 Staging
- •17.5.9.1 Fisch Staging
- •17.5.9.2 Radkowski Staging
- •17.5.10 Treatment
- •17.5.10.1 Surgery
- •17.5.10.2 Outcome
- •17.5.10.3 Complications
- •17.5.10.4 Radiotherapy
- •17.5.10.5 Chemotherapy
- •17.5.10.6 Hormonal Therapy
- •17.5.10.7 Spontaneous Regression
- •17.6 Lymphatic Malformation
- •17.6.1 Introduction
- •17.6.2 Genetics
- •17.6.3 Clinical Presentation
- •17.6.4 Diagnosis
- •17.6.5 Treatment
- •17.6.5.1 Observation
- •17.6.5.2 Sclerotherapy
- •17.6.5.3 Surgery
- •17.6.5.4 Other Modalities
- •17.6.5.4.1 Novel Agents
- •17.7 Cystic Hygroma
- •17.8 Lymphoma
- •17.8.1 Hodgkin’s Lymphoma
- •17.8.2 Non-Hodgkin’s Lymphoma
- •17.8.4 Diagnosis
- •17.8.4.1 Haematology
- •17.8.4.2 Imaging
- •17.8.4.3 Surgery
- •17.8.7.1 Radiation Therapy
- •17.9 Langerhans Cell Histiocytosis
- •17.9.1 Epidemiology
- •17.9.2 Pathogenesis
- •17.9.3 Clinical Feature
- •17.9.4 Investigations
- •17.9.5 Treatment
- •17.9.5.1 Solitary or Single-System Involvement
- •17.9.5.2 Multisystem Involvement
- •17.9.5.3 Induction Chemotherapy
- •17.9.5.4 Continuation Chemotherapy
- •17.9.5.5 Post-treatment Follow-Up
- •17.9.5.6 Relapsed or Refractory Disease
- •References
- •18.1.1 Case Illustration 1
- •18.1.2 Surgical Steps
- •18.2 Case Illustration 2
- •18.3 Stomatoplasty
- •18.5.1 Case Illustration
- •18.6.1 Case Illustration
- •18.7 Deep Lobe Parotidectomy
- •18.8 Conclusion
- •References
- •19.1 Introduction
- •19.2.1 Cross-Sectional Imaging
- •19.2.2 Emerging Applications
- •19.2.6 PET-MR
- •19.2.8 Others
- •19.2.8.1 SPECT
- •19.2.8.2 Elastography
- •19.2.8.3 Fluoroscopy
- •19.2.8.4 Narrowband Imaging
- •19.2.9 Biochemical Investigations
- •19.2.10 Imaging Biomarkers
- •19.3.1 Neck Dissection
- •19.5 Oral Cavity Cancer (OCSCC)
- •19.7 Hypopharyngeal Cancer
- •19.8 Nasopharynx Carcinoma (NPC)
- •19.10 Salivary Gland Malignancy
- •19.10.1 Parotid Tumors
- •19.11 Intraoperative Facial Nerve Monitoring
- •19.12.1 Treatment
- •19.13 Parapharyngeal Space Tumors (PPS)
- •19.14.2 Diagnostic Controversy
- •19.14.5 Optimal Resection Margins
- •19.15.1 Nonsurgical Treatment
- •19.16.2 Induction Chemotherapy
- •19.19.1 Targeted Therapy
- •19.19.2 Immunotherapy
- •19.19.3 Cancer Stem Cells (CSCs)
- •19.20 Conclusion
- •References

304
C. Saraniti and B. Verro
a
c
b
d
Fig. 12.9 Subisthmic tracheostomy: (a) incision of thyroid-pericardial lamina, (b) ligation of ima veins, (c) horizontal
incision between two tracheal rings, (d) creation of Bjork’s ap
9. Pharyngotomy
Access to the hypopharynx will be per-
formed by horizontal pharyngotomy, superiorly and medially to the pedicle, allowing to
vallecula. This pharyngotomy will allow the
epiglottis to be overturned outwards by tractioning with a transxed stitch or grasping
forceps (Fig.12.11).
dissect the mucosa of the glosso-epiglottic

12 Laryngeal Disease andTumours andIts Related Surgery
305
a
Fig. 12.10 Exeresis of the pre-epiglottic space: (a) detachment of external perichondrium of thyroid cartilage, (b) sec-
tion of thyro-hyoid membrane
a
b
b
c
Fig. 12.11 (a) Epiglottis’ traction by a transxed stitch, (b) vertical section of pharyngo-laryngeal wall, (c) horizontal
section through the ventricular oor, (d) detachment of the supraglottis from the glottis
d

306
C. Saraniti and B. Verro
10. Section of ary-epiglottic fold, false vocal
fold and medial wall of the piriform sinus up
to the ventricular oor (pharyngolaryngeal
wall)
11. Vertical section of the pharyngoepiglottic
fold (Fig.12.11)
12. Horizontal section through the ventricular
oor (Fig.12.11)
13. Detachment of the supraglottis from the glot-
tis (Fig.12.11)
The section line passes from the oor of
the ventricle, along the previously performed
thyrotomy line, to the anterior commissure.
The same will be performed contralaterally.
14. Laryngeal closure and suspension
The perichondrium, previously spared,
can be sutured to the ventricle oor in order
a
to cover the exposed para-glottic space. The
pexy can start laterally by suturing the
mucosa of the lateral wall of the piriform
sinus with the mucosa of the lateral pharynx
wall (Fig.12.12).
15. Pexy
Pexy is usually performed with three sin-
gle stitches (Fig.12.12):
– A median passing from the lower border
of the thyroid cartilage to include the
tongue base and the hyoid bone.
– Two laterals that pass the lower edge of
the thyroid cartilage and internally follow
the medial wall of the thyroid ala, lateral
to the vocal cord: Superiorly, the needle
passes above the intermediate digastric
tendon avoiding the lingual artery. The
b
c
Fig. 12.12 (a) Glottic plane with arytenoids, (b) perichondrium sutured to ventricle oor in order to cover the paraglot-
tic space, (c) pexy with three single stitches

12 Laryngeal Disease andTumours andIts Related Surgery
307
suture used is absorbable, 0 or 1, with a
curved atraumatic needle, with a diameter
of 48mm.
12.10.2 Horizontal Supracricoid
Laryngectomy: OPHL
TypeII
Succo etal. dened OPHL type II as the gold
standard procedure in case of supraglottic T3
and glottic T3 carcinoma with true vocal cord
xity [29]. It consists of the removal of the epiglottis, the entire thyroid cartilage, Morgagni’s
ventricle, both true and false vocal cords and
the pre- epiglottic and para-glottic spaces.
Therefore, the only preserved structures are the
cricoid cartilage, at least one mobile arytenoid
cartilage and the hyoid bone [41]. Therefore,
this surgery allows radical oncology and preservation of organ function with a better quality
of life than that of patients who have undergone total laryngectomy with voice prosthesis
placement [42], with a 5-year OS rate greater
than 82.10%, a 5-year SS rate greater than
89.19% and a 5-year LC rate greater than
82.46% [41, 43, 44].
Furthermore, as regards the main indications
for OPHL type II, the surgical procedure must be
distinguished in the two subtypes. OPHL type IIa
or CHEP (crico-hyoido-epiglottopexy)
(Table12.2) is indicated in these stages: (1) glottic T2 tumours with xity of the vocal cord without involvement of the corresponding arytenoid
and (2) glottic T2 tumours with extension to the
ventricle, at the false vocal fold, to the infrahyoid epiglottis and/or with impaired vocal cord
motility. OPHL type IIb with CHP (cricohyoidopexy) (Table12.3) is indicated in (1) glottic T2 tumours with bilateral invasion, (2) glottic
T3 tumours originating from the anterior commissure and involving the pre-epiglottic space,
(3) supraglottic or transglottic T2 tumours with
invasion of the pre-epiglottic space and/or vocal
cord xity with normal motility of the corresponding arytenoid and (4) supraglottic or transglottic T4 tumours with partial involvement of
the thyroid ala without exceeding the external
perichondrium [41, 45].
However, OPHL type II is contraindicated in
the following situations: (1) xity of both arytenoid cartilages, (2) invasion of the crico-thyroid
membrane, (3) invasion of the cricoid cartilage,
(4) extension of the tumour to the glossoepiglottic vallecula and/or invasion of the thyrohyoid membrane, (5) invasion of the hyoid bone
and (6) extension of the tumour beyond the external perichondrium of the thyroid cartilage [45].
Finally, the main problem related to this
surgery is represented by the impairment of
Table 12.2 Horizontal supracricoid laryngectomy with crico-hyoido-epiglottopexy
OPHL type IIa
OPHL type IIa+ARY
ARY: arytenoid
Image drawn by Vincenzo Verro

308
C. Saraniti and B. Verro
Table 12.3
OPHL type IIb (with crico-hyoidopexy)
OPHL type IIb+ARY
ARY: arytenoid
Image drawn by Vincenzo Verro
Horizontal supracricoid laryngectomy with crico-hyoidopexy
swallowing function with consequent risk of
aspiration and aspiration pneumonia [46].
Anyway, over time, the patient will implement a
compensation mechanism represented by the
antero-medial rotation of the residual arytenoid
with closure of the airways during swallowing
[43].
12.10.2.1 Surgical Technique
1. Skin incision
2. Detachment of the myo-cutaneous ap
3. Incision of the deep cervical fascia along the
anterior border of the sternocleidomastoid
muscle
4. Exposure of the larynx
5. Larynx skeletonization (Fig.12.13)
– Section of the inferior constrictor pharyn-
geal muscles
– Detachment of both piriform sinuses
– Section of the small cornu of the thyroid
cartilage, which is always performed in
order to avoid recurrent nerve injuries
during the disarticulation manoeuvre
6. Management of the laryngeal neurovascular
pedicle
7. Subisthmic tracheostomy
8. Inferior endolaryngeal access (Fig.12.14)
Transection of the crico-thyroid muscles
and of the crico-thyroid membrane, at the
upper edge of the cricoid ring: The mucous
membrane of the cricoid ring can be
detached and removed in order to have an
additional margin of healthy tissue. This
surgical step is common to OPHL type IIa
and IIb.
9. Superior endolaryngeal access (Figs. 12.14
and 12.15)
– OPHL type IIa: Horizontal section of the
thyro-hyoid membrane, of the tissues of
the pre-epiglottic space and of the epiglottis, along the plane corresponding to the
upper edge of the thyroid cartilage and
within two vertical lines passing through
the small thyroid cornu. Preservation of
the suprahyoid portion of the epiglottis
will ensure good tension of the aryepiglottic folds
– OPHL type IIb: Access is the same as that
of OPHL type I
10. Endolaryngeal resection
After the two accesses are performed and
thus entering the larynx inferiorly and superiorly, the endolaryngeal inspection is
reached by a full-thickness cut from the less
involved side, taking care to spare the lateral
crico-arytenoid muscle and the cricoarytenoid unit. This section encompasses the
false cord, the posterior ventricular cornu

12 Laryngeal Disease andTumours andIts Related Surgery
309
a
b
c
Fig. 12.13 (a) Detachment of piriform sinus, (b, c) section of the small cornu of the thyroid cartilage
a
Fig. 12.14 OPHL type II: (a) superior endolaryngeal access, (b) superior and inferior endolaryngeal accesses
b

310
C. Saraniti and B. Verro
a
Fig. 12.15 OPHL type IIa: (a) horizontal section along the upper edge of the thyroid cartilage, (b) after endolarynx
section and exeresis
and the true vocal cord at the vocal apophysis.
The integrity of the piriform sinus is guaran-
b
exeresis of the lower para-glottic
space.
teed. This section is also performed contralaterally in case of sparing of both
arytenoids.
– OPHL type II + ARY: The sectioned
muco-cartilage ap is reversed contralaterally after manual fracture of the thyroid
shield in order to assess the real extension
of the tumour and to continue with the
next section under visual control.
Endolaryngeal incisions should be made
no less than 2mm away from the lesion.
This surgical time includes:
If the maintenance of both arytenoids is
expected, the external detachment must be
performed laterally to the lateral cricoarytenoid muscles in order to safeguard their
integrity.
Once the exeresis is complete, on the side
where the arytenoid is removed, it is advisable to reposition the medial wall of the piriform sinus to the cricoid in order to ensure a
wider piriform sinus. Actually, on the side
where the arytenoid is present, the tension of
the piriform sinus’ inlet will be guaranteed
• A hypoglottic horizontal section up to
the midline, below the crico-arytenoid
joint
• A section of the mucosa along the edge
of the arytenoid
• A section along the ary-epiglottic fold
bordering the medial wall of the piriform sinus
by the pexy.
11. Pexy
It is carried out by three single points, one
median and two laterals, passing through the
lower edge of the cricoid with 0 and 1–0
thread, 38 mm diameter, atraumatic needle
(Fig.12.16).
– OPHL type IIa: The median suture point
will include, as the rst step, the residual
• In this case, the excision of one arytenoid includes the detachment of the
lateral crico-arytenoid muscle from the
cricoid in order to ensure complete
epiglottis and a portion of the tongue
base, as close as possible to the lingual V;
as the second step, the body of the hyoid
bone is included. This suture can include

12 Laryngeal Disease andTumours andIts Related Surgery
311
a
Fig. 12.16 (a) Crico-hyoido-epiglottopexy, (b) crico-hyoidopexy
the epiglottis, tongue base and hyoid bone
in one step. The two lateral stitches will
pass laterally to the median point, at the
limit between the plate and the ring. These
will also include the residual epiglottis
b
Table 12.5
tracheo-hyoidopexy
OPHL type IIIb
(with
tracheohyoidopexy)
and the tongue base and will pass centrally to the small cornu of the hyoid bone
to avoid the lingual artery
– OPHL type IIb: The superior passage to
the tongue base occurs as per the supraglottic laryngectomy (OPHL type I)
12. Pexy protection (optional)
The thyroid gland can be used to protect
and reinforce the crico-hyoid-pexy. Being
free on the lower side from the thyro-pericardial membrane, its raising will be facilitated.
Then, the thyroid body is sutured to the
suprahyoid muscles with stitches passing
through the upper edge of the gland, avoiding
the medial branch of superior thyroid artery.
OPHL type IIIb + ARY
ARY: arytenoid
Image drawn by Vincenzo Verro
Table 12.4
tracheo-hyoido-epiglottopexy
OPHL type IIIa (with
tracheo-hyoidoepiglottopexy)
Horizontal supratracheal laryngectomy with
Horizontal supratracheal laryngectomy with
12.10.3 Horizontal Supratracheal
Laryngectomy: OPHL
TypeIII
The horizontal supratracheal laryngectomy
(Tables 12.4 and 12.5) was introduced in 2006 to
OPHL type IIIa + ARY
ARY: arytenoid
Image drawn by Vincenzo Verro

312
C. Saraniti and B. Verro
respond to the need of a surgery that would guarantee the preservation of the laryngeal function
with an excellent long-term locoregional control
in those cases which cannot be solved by a less
extensive demolition, i.e. OPHL type II [29].
Therefore, this type of OPHL is indicated in
the case of (1) glottic T2 tumours with anterior or
lateral extension at the subglottic level and invasion of the elastic cone up to the cricoid ring; (2)
T3 transglottic tumours with involvement of the
upper para-glottic space and subglottic extension; (3) T3 glottic-subglottic tumours with
involvement of the para-glottic space, elastic
cone and external perichondrium of the thyroid
cartilage; and (4) T4a tumours with limited
extralaryngeal, anterior or lateral extension [29,
47]. Conversely, it is contraindicated in case of
(1) T4a supraglottic carcinoma with involvement
of the tongue base or invasion of the hyoid bone,
(2) N3, (3) T4a tumours with involvement of the
rst tracheal ring and (4) T3 glottic-subglottic
tumours involving the posterior crico-arytenoid
muscle and the submucosa of the sinus piriform
[29, 47].
This surgical technique includes the resection
of the glottic and subglottic plane, thyroid cartilage and amount of the cricoid cartilage depending on the tumour extension but always with
preservation of at least one crico-arytenoid unit
[48]. Assuming that a more extensive exeresis is
correlated with a more compromised laryngeal
function, Schindler et al. compared various
parameters (swallowing, voice and speech and
quality of life) between OPHL type IIa and IIIa
and demonstrated the absence of statistically signicant differences between the two long-term
surgical techniques [37]. The most frequently
reported complication is known as post-operative
laryngeal obstruction (POLO), which can be
treated with CO2 laser surgery [19, 29].
In conclusion, OPHL type III can be considered an effective therapeutic strategy in the case
of glottic or transglottic tumours with subglottic
extension as an alternative to the chemoradiotherapy protocol, with oncological radicality and,
at the same time, partial preservation of the larynx [48].
12.10.3.1 Surgical Technique
1. Skin incision
2. Detachment of the myo-cutaneous ap
3. Incision of the deep cervical fascia along the
anterior border of the sternocleidomastoid
muscle
4. Exposure of the larynx
5. Larynx skeletonization
– Section of the inferior constrictor pharyn-
geal muscles
– Detachment of both piriform sinuses
6. Management of the laryngeal neurovascular
pedicle
7. Subisthmic tracheostomy
8. Inferior access
The horizontal section passes through the
lower edge of the cricoid cartilage.
9. Superior access
– OPHL type IIIa: the superior approach is
comparable to an OPHL type IIa
– OPHL type IIIb: the superior approach is
the same as OPHL type I and IIb
10. Cricoid resection
There are two types of cricoid resection
– Cricoid arches
– Cricoid arches + half cricoid plate + CAU
11. Piriform sinuses
If the resection does not involve half cri-
coid plate, the piriform sinuses will be xed
with sutures to the lateral part of the plate
and possibly also to the rst tracheal ring.
In the case of resection of a half cricoid
plate, the ipsilateral retro-cricoid mucosa
will be xed with sutures to the residual
plate, the section line on the plate and the
pars membranacea of trachea.
12. Pexy
In this case, the pexy is performed
between the rst tracheal ring at the bottom
and follows the same steps as OPHL type I
and type II above.
12.11 Total Laryngectomy
Total laryngectomy was performed for the rst
time in 1873 by Billroth [49] and, until a few
decades ago, has represented the therapeutic gold

12 Laryngeal Disease andTumours andIts Related Surgery
313
standard for advanced laryngeal cancers. To date,
the conservative surgery has reduced total laryngectomy only in limited cases, i.e. in case of T3
and T4a laryngeal carcinoma, where conservative
laryngectomy or non-surgical therapy failed (the
so-called “salvage surgery”) [50, 51]. Several
studies have demonstrated the advantage of total
laryngectomy over chemoradiotherapy in terms
of survival and quality of life [52, 53], even in
case of T4a where the surgical approach represents the best therapeutic option [54]. Obviously,
the surgical indication and its effectiveness in
terms of OS, LC and quality of life depend on the
patient, his/her age and comorbidities.
Total laryngectomy involves impairment in
breathing, speech and swallowing; therefore, the
rehabilitation phase is also fundamental as well as
the demolition phase. Thus, breathing is ensured
by the tracheostomy which, differently from
OPHL interventions, in this case will be permanent. With regard to phonation, instead, various
strategies for voice rehabilitation have been developed over the years: the tracheoesophageal prosthesis (TEP), the oesophageal speech or the
electronic larynx [55]. According to many studies,
TEP would represent the best solution for voice
restoration because it is more similar to normal
phonation in terms of sound and functioning [56,
57]. Despite this, it would not be correct to dene
TEP as an absolute gold standard, since the best
voice restoration strategy depends on the patient
with his/her comorbidities and preferences [58].
Swallowing can be affected by total laryngectomy; about 40% of laryngectomized patients can
develop dysphagia even years after surgery and
especially after adjuvant chemoradiotherapy [59,
60]. Actually, laryngectomy inevitably causes an
alteration of the physiology of swallowing with
an increased pharyngeal transit time of the bolus
and pharyngeal residue and a reduced peristaltic
contraction of the oesophagus [61].
Moreover, other complications may affect the
post-operative course of total laryngectomy: pharyngocutaneous stula (about 28% of cases) or
tracheo-oesophageal stula (5% of cases), pharyngeal stenosis (about 14% of cases) or tracheostomy stenosis (about 20% of cases) [62].
Nevertheless, total laryngectomy remains the
most preferable choice in case of stage IV laryngeal cancer compared to chemoradiotherapy
[63].
12.11.1 Surgical Technique
1. Skin incision
2. Detachment of the myo-cutaneous ap
3. Incision of the deep cervical fascia along the
anterior border of the sternocleidomastoid
muscle
4. Dissection of the fascia in the latero-medial
direction
5. Section of omohyoid and sternohyoid
muscles
Section of the omohyoid muscle along the
anterior edge of the sternocleidomastoid
muscle and lower section of the sternohyoid
muscle are performed. Superiorly, these muscles are dissected at the hyoid attachment.
6. Lower section of the sternothyroid muscle
7. Section of the thyro-hyoid muscle at insertion on the hyoid
NB: Management of strap muscles: the
strap muscles can be removed before laryngectomy or left and removed in en bloc modality
with larynx, especially in case of T4a with inltration of strap muscles, platysma and skin.
8. Thyroid time
Fig. 12.17 Detachment of thyroid lobes from the laryngeal-tracheal axis
Соседние файлы в папке Библиотека им академика М.И. Перельмана
